MOLGRAMOSTIM IS A GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF), A HAEMATOPOIETIC GROWTH FACTOR THAT STIMULATES THE DEVELOPMENT OF WHITE BLOOD CELLS, PARTICULARLY GRANULOCYTES, MACROPHAGES, AND MONOCYTES. IT IS USED TO TREAT OR PREVENT NEUTROPENIA IN PATIENTS RECEIVING MYELOSUPPRESSIVE CANCER CHEMOTHERAPY AND TO REDUCE THE PERIOD OF NEUTROPENIA IN PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION. IT IS ALSO USED TO REDUCE GANCICLOVIR-INDUCED NEUTROPENIA.